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Underlying Pathophysiology

Introduction

Significance of Pathophysiology
The spread of Zika has increased alarmingly over the past few years.

The Zika virus (Zika) was first discovered in 1947 in Uganda, with only 14 cases
documented before 2007 (Centers for Disease Control and Prevention, 2016).
Over the last two years, however, this virus, formerly confined to the tropical
regions of Africa and South East Asia, has been reported in South and Central
America, Mexico, parts of the Caribbean, Polynesia, with the reports continuing to
grow. In February, 2016, the World Health Organization reported that Zika has
been elevated to a Public Health Emergency of International Concern.
The spread of Zika is alarming because it has been associated with severe fetal
brain defects, Guillian-Barre syndrome (GBS) and encephalopathy. Transmission
is primarily through the Aedes aegypti and Aedes albopictus mosquitos and may
also be spread by sexual contact. Further, many of those infected show no signs
or symptoms, making accidental spread possible. As of this date, there is no
vaccine or treatment (CDC, 2016).
This topic is significant because it underlines the importance of awareness and
prevention for those that may be at risk of contracting or spreading Zika. It is very
important that health care workers are educated on the disease process and
nursing implications of this potentially devastating virus.

Signs and Symptoms
According to the Centers for Disease Control, only an estimated 20% of
people infected with the Zika virus will ever show symptoms (2016). The most
frequently reported symptoms are:
•
•
•
•
•

Fever
Rash
Conjunctivitis
Muscle and joint pain
Headache

The illness usually presents as a mild cold or flu which can last up to a week.
For this reason, many people do not realize they have been infected and do
not seek medical treatment. This makes tracking nearly impossible.

Viruses are intracellular parasites that depend on host cells. The
structure is a ribonucleic acid (RNA) or deoxyribonucleic acid (DNA),
with a protective coating. To fight viral infections, the body will
release interferons that block intracellular viral replication. It does
this by recognizing the antigenic change on an infected cell’s surface.
However, enveloped viruses release through budding, in which viral
parts are coated with the healthy cell’s original plasma membrane,
making recognition much more difficult.
When a mosquito with Zika bites a human, it injects the virus,
through its saliva, below the epidermis. Dermal fibroblasts,
keratinocytes and immature dendritic cells are all presumed targets of
the virus and support their replication (Lazear, Stringer & de Silva,
2016). Zika appears to promote autophagosome formation to
replicate, then triggers cell apoptosis to disseminate the virus (Kruger,
2016).
The Zika virus is:
•

Enveloped, icosahedral positive strand RNA virus

•

Related to yellow fever, dengue, West Nile, and Japanese
encephalitis viruses

•

Found mainly in the saliva of the Aedes mosquitos

•

Is transmitted from mosquito to human, mother to child, through
sexual contact, blood transfusion and laboratory exposure (CDC,
2016)

•

Zika has also been identified in human saliva, urine and breast
milk (Malone et a., 2016)

•
•
•
•

Between 1947 and 2007 – 14 cases with no deaths, hospitalizations or
neurological complications reported.
2007, 49 cases were confirmed on the island of Yap.
2014, 400 cases were reported in French Polynesia with outbreaks in
Easter Island, the Cook Islands and New Caledonia.
Reports now indicate an association with congenital malformations,
severe neurological and autoimmune complications including
microcephaly and GBS
(Pocock & Rezaeian, 2016)

Experts speculate that the rise in communicability and virulence could be
due to antigenic drift, extreme weather patterns, travel and/or urbanization,
however, the definitive cause of the emergence remains uncertain.
In April, 2016, the CDC announced its position that Zika causes
microcephaly and other birth defects. While there is no “smoking gun,” the
link between Zika and birth defects is partially due to timing - dramatic
increases in infants born with microcephaly appeared along with dramatic
increases in confirmed Zika infections. In addition, Zika has been detected in
amniotic fluid and tissues of many newborns born with microcephaly and a
significant proportion of Zika infected women had fetuses that developed birth
defects including microcephaly (Weaver et al., 2016).
The CDC defines microcephaly as a condition where a “…baby’s brain has
not developed properly during pregnancy or has stopped growing after birth
which results in a smaller head size” (2016). Problems with this condition
include seizures, developmental and intellectual delays, hearing and vision
problems, feeding problems and difficulty with movement and balance. The
severity ranges from mild disabilities to death.
In addition to birth defects, GBS has also been linked to Zika. Again, this is
partially due to timing - a cluster of GBS cases during the French Polynesia Zika
outbreak in 2013, and increases in GBS in several other countries that were
experiencing a Zika epidemic (Weaver et al., 2016). GBS is a rare autoimmune
disease usually caused by a bacterial or viral infection. It can cause pain,
weakness or progressive paralysis that moves up the body. Weakness that
involves the respiratory muscles may require mechanical ventilator support
and progression to cardiovascular collapse could be fatal.

Implications for
Nursing Care
Because there is no treatment or vaccine for Zika, health care
providers should focus their attention on education and
prevention. It is important to understand the risks of traveling to
Zika affected areas, how to protect yourself and your families, and
what to do if you suspect you are infected.
*Prevent mosquito bites by wearing long sleeve shirts, use
effective insect repellent, when outside use barriers such as nets
and screens. Stay in air conditioned places when possible –
mosquitoes hate the cold.
*Involve the community by organizing clean up campaigns.
Remove standing water where mosquitos breed and lay their
eggs.
*Counsel pregnant women or women of child bearing years on
the risks and precautions of traveling to areas affected by Zika or
warm areas where mosquito-borne transmission may occur.
*Counsel men on the risks of contracting Zika, GBS and possibility
of transmitting the virus through sexual contact. Sexually contact
that results in a pregnancy, or transmission to an already
pregnant partner, could impact the health of the fetus.
*Provide information to those already infected with Zika on how
to prevent transmission to others, prenatal care, monitor infants
for developmental milestones and signs of birth defects, and signs
and symptoms of GBS.
*Ethical considerations include limiting travel, contraception,
delayed family planning, and other issues that may be very
difficult to confront.

Figure 3. Ludmilla Hadassa Dias de Vasconcelos was born
November, 2016 with microcephaly in Recife, Brazil. Getty
Images, 2016.

Conclusion
Zika has been in existence for decades, however, the
pandemic spread and recent links to debilitating neurological
disorders and devastating birth defects has the scientific
community racing to control its spread and harm. Though
experts now agree that Zika causes microcephaly and GBS, the
causal link has not been determined.

Figure 1. ZIKA Virus by World Health Organization, 2016.

Figure 2. ZIKA summary timeline by T. Unwin, 2016.

In the absence of facts, the public may “fill in the blanks”
with inaccurate, inappropriate or agenda-driven material. As
researchers continue to examine the dangers that Zika may
present to the public, health care professionals should make a
concerted effort to stay abreast of the most recent
developments to properly educate themselves and their
patients on the present and future implications of this virus.
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